Lung Cancer Research Foundation and ALK Positive Announce New Research Partnership
NEW YORK, June 15, 2023 /PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) and the ALK Positive Inc. (ALK Positive) announce the expansion of its current research partnership to fund $2 million in ALK-positive related lung cancer projects over three years. The aim of this research is to advance high-impact research focused upon transforming care and improving outcomes for patients with ALK-positive non-small cell lung cancer (NSCLC).
- NEW YORK, June 15, 2023 /PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) and the ALK Positive Inc. (ALK Positive) announce the expansion of its current research partnership to fund $2 million in ALK-positive related lung cancer projects over three years.
- The aim of this research is to advance high-impact research focused upon transforming care and improving outcomes for patients with ALK-positive non-small cell lung cancer (NSCLC).
- ALK positive lung cancers are seen in half of lung cancers diagnosed before age 50, nearly one third diagnosed before 40, and occurs in patients in their teens and twenties.
- Both LCRF and ALK Positive are committed to investing in research that will improve therapeutic options and increase survivorship."